Tiny RNA clues may reveal why prostate cancer fights back
NCT ID NCT04662996
First seen Feb 15, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This study looked for tiny molecules called microRNAs in the blood of 33 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to see if certain microRNA patterns could predict whether a patient's cancer would resist chemotherapy or newer hormone drugs. Researchers hope these clues will help doctors choose the right treatment from the start.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital of Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.